Alexander L Weis insider trades: Oncovista Innovative Therapies (OVIT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alexander reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2011 | OVIT | ↑ Buy | 37,200 | $0.60 | $22K | Direct | Jul 5, 2011 (5d) |
| Mar 8, 2011 | OVIT | ↑ Buy | 34,000 | $0.44 | $15K | Direct | Mar 10, 2011 (2d) |
| Jan 3, 2011 | OVIT | ↑ Buy | 135,000 | $0.31 | $42K | Direct | Jan 11, 2011 (8d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alexander L Weis's insider trades
Alexander L Weis is President, CEO, CFO, Secretary at Oncovista Innovative Therapies (OVIT). Since Jan 3, 2011, Alexander has reported 3 open-market purchases worth $79K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OVIT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.